T61 is a New Protein That Supports Retinal Axon Outgrowth and Regeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$68,852
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
G2004035
Summary
Glaucoma can be viewed as a neurodegenerative disease in which retinal nerve cells degenerate. These nerve cells are responsible for carrying signals from the retina to the brain, and their loss results in blindness. A novel treatment for glaucoma would be to promote the regeneration of lost retinal nerve cells. Dr. Monnier has identified a protein (T61) that supports nerve growth, and its characterization represents an important step toward a molecular understanding of the environment that retinal nerve cells need in order to regenerate. Dr. Monnier believes that the lack of regeneration is due to the inhibitory factors in the environment of retinal nerve cells. He plans to first clone this protein, and then to perform a biochemical characterization and study its interaction with other proteins. He hopes to confirm the hypothesis that T61 supports retina nerve cell regeneration by showing that T61 allows nerve cell growth even in the presence of inhibitory factors that hamper regeneration. This is a long-term study that could have important consequences for the development of new treatments for glaucoma.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison